These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Management of otitis media with antimicrobial agents. Klein JO Curr Clin Top Infect Dis; 2000; 20():174-88. PubMed ID: 10943524 [No Abstract] [Full Text] [Related]
43. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Steele RW Clin Pediatr (Phila); 1998 Dec; 37(12):757-8. PubMed ID: 9864653 [No Abstract] [Full Text] [Related]
44. Comparison of ampicillin and amoxicillin in the treatment of otitis media in children. Howie VM; Ploussard JH; Sloyer J J Infect Dis; 1974 Jun; 129(0):suppl:S181-4. PubMed ID: 4152132 [No Abstract] [Full Text] [Related]
45. Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice. Labreche MJ; Graber CJ; Nguyen HM Clin Infect Dis; 2015 Nov; 61(9):1446-52. PubMed ID: 26105168 [TBL] [Abstract][Full Text] [Related]
46. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae]. Sakata H Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154 [No Abstract] [Full Text] [Related]
47. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. del Castillo F; Baquero-Artigao F; Garcia-Perea A Pediatr Infect Dis J; 1998 Feb; 17(2):94-7. PubMed ID: 9493802 [TBL] [Abstract][Full Text] [Related]
48. The pneumococcus in the new millennium. McCormack JG Med J Aust; 1999 Feb; 170(4):147-8. PubMed ID: 10078174 [No Abstract] [Full Text] [Related]
49. Experts release white paper on antimicrobial use and resistance in Iowa. Hill D Iowa Med; 2001; 91(5):20-1. PubMed ID: 11641997 [No Abstract] [Full Text] [Related]
50. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. Bottenfield GW; Burch DJ; Hedrick JA; Schaten R; Rowinski CA; Davies JT Pediatr Infect Dis J; 1998 Oct; 17(10):963-8. PubMed ID: 9802654 [No Abstract] [Full Text] [Related]
51. Encouraging news from the antibiotic resistance front. Dean NC Chest; 2003 Aug; 124(2):423-4. PubMed ID: 12907521 [No Abstract] [Full Text] [Related]
52. Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics. Yang R; Sabharwal V; Shlykova N; Okonkwo OS; Pelton SI; Kohane DS JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282835 [TBL] [Abstract][Full Text] [Related]
53. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. Eldan M; Leibovitz E; Piglansky L; Raiz S; Press J; Yagupsky P; Leiberman A; Dagan R Pediatr Infect Dis J; 2000 Apr; 19(4):298-303. PubMed ID: 10783018 [TBL] [Abstract][Full Text] [Related]
54. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. Friedland IR; McCracken GH N Engl J Med; 1994 Aug; 331(6):377-82. PubMed ID: 8028618 [TBL] [Abstract][Full Text] [Related]
55. [Appearance in East Germany of a strain of Streptococcus pneumoniae with reduced sensitivity to penicillin]. Dinger E; Witte W; Heuck D; Krumbügel B Z Arztl Fortbild (Jena); 1981 Nov; 75(21):1001-3. PubMed ID: 6978572 [No Abstract] [Full Text] [Related]